The news comes days after early-stage data showed Medicago’s plant-based vaccine candidate produced virus-fighting antibodies in all volunteers. Medicago, backed by cigarette maker Philip Morris International, is Canada’s most advanced COVID-19 vaccine project, but lags larger, global rivals. Medicago has said a lower dose of the vaccine will be used for further trials, for which Dynavax Technologies’ adjuvant will not be used as before. …read more
Source:: Yahoo Finance
